ALLO
UNKNOWNAllogene Therapeutics, Inc.
CIK: 0001737287
Last activity: 2 weeks ago
Financial Metrics
As of Dec 31, 2025 (10-K)
Insider Roster (6 total, 6 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
|
Chang David D
President and CEO
|
0 | 2 | -$289K |
5,150,599 shares
$12.72M
|
|
Roberts Zachary
EVP of R&D
|
0 | 2 | -$104K |
581,166 shares
$1.03M
|
|
Beneski Benjamin Machinas
SVP, Chief Technical Officer
|
0 | 3 | -$44K |
198,205 shares
$490K
|
|
Parker Geoffrey M.
CHIEF FINANCIAL OFFICER
|
0 | 1 | -$42K |
1,252,795 shares
$2.20M
|
|
Douglas Earl Martin
SVP, General Counsel
|
0 | 1 | -$40K |
564,948 shares
$994K
|
|
Yoshiyama Annie
SVP, Finance
|
0 | 1 | -$7K |
130,322 shares
$224K
|
Recent Transactions
47,763 shares @ $2.47
$118K
Mar 16, 2026
4,835 shares @ $2.47
$12K
Mar 16, 2026
7,132 shares @ $2.60
$19K
Mar 2, 2026
95,269 shares @ $1.80
$171K
Feb 2, 2026
35,700 shares @ $1.77
$63K
Feb 2, 2026
24,001 shares @ $1.76
$42K
Feb 2, 2026
22,900 shares @ $1.76
$40K
Feb 2, 2026
7,549 shares @ $1.73
$13K
Feb 2, 2026
4,167 shares @ $1.72
$7K
Feb 2, 2026
26,269 shares @ $1.56
$41K
Jan 21, 2026
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.